B. Braun: B. Braun introduces readytoactivate Cefazolin 3 gram premix in DUPLEX Containers
B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced the launch of its new Cefazolin 3 g, the latest cefazolin dose addition to the DUPLEX Container portfolio.
Read full article »
CEO
B. Braun is a Germany-based medical device company that develops and markets products such as anesthesia and extracorporeal blood therapy systems for the healthcare industry.
Read more